Patents Assigned to Cortenda AB
  • Patent number: 6410339
    Abstract: The use of cortisol agonist for preparing a system for diagnosis of the Metabolic Syndrome and related conditions as belly fatness, insulin resistance including increased risk of developing senile diabetes, i.e., diabetes type II, high blood fats and high blood pressure, in which system the dose of cortisol agonist is in an interval where a difference is obtained in the inhibitory effect of the autoproduction of cortisol in individuals suffering from the Metabolic Syndrome, compared to normal values.
    Type: Grant
    Filed: February 26, 1998
    Date of Patent: June 25, 2002
    Assignee: Cortenda AB
    Inventor: Per Märin